GRGDSP can be used to modify the surface of cardiovascular implants, such as vascular grafts, to promote endothelialization; it is a synthetic linear RGD peptide and integrin inhibitor that blocks tumor cell adhesion to vascular endothelial cells and limits metastasis; it is widely used as a soluble integrin-blocking RGD-based peptide in integrin research.